Optometry News

A deep learning system achieved an accuracy of more than 90% in distinguishing arteritic from nonarteritic anterior ischemic optic neuropathy using only color fundus images, according to a study published in JAMA Ophthalmology.

A number of studies have shown that, among patients undergoing cataract surgery, 80% would seriously consider a refractive implant if they fully understood what it offers.

Bausch + Lomb has announced that its Soothe antibiotic drops have been approved by Health Canada for over-the-counter use in the treatment of external infections of the eye and ear, according to a company press release.

Ocuphire Pharma has acquired Opus Genetics in an all-stock transaction, with the aim of expanding its position in the gene therapy space for the treatment of inherited retinal diseases, according to a press release.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Douglas Love, president and CEO of Annexon Biosciences, discusses the company’s phase 3 program in geographic atrophy.

Nonqualified plans offer a valuable alternative or supplement to qualified retirement plans for physicians seeking to enhance their retirement savings.

CHICAGO — Many diseases can present as dry eye, leading to missed diagnoses and failed treatment, according to a speaker here.

A catenary curve-based, extended depth of focus multifocal contact lens provided full functional vision range, under naturally varying conditions, for older adults with advanced presbyopia, according to a study in Clinical Ophthalmology.

CHICAGO — In this Healio Video Perspective from the AAO meeting, William B. Trattler, MD, discusses a study that evaluated age and keratoconus progression.

Okyo Pharma has announced that screening and recruitment has been initiated for a phase 2 trial of OK-101 to treat neuropathic corneal pain, with plans to enroll 48 patients, according to a company press release.